Acumen Pharmaceuticals is developing an Alzheimer’s disease drug that it believes offers advantages compared to other approaches—including the recently approved Biogen therapy. A small clinical trial ...

Acumen Pharmaceuticals has early clinical evidence that its Alzheimer’s disease candidate safely reduces amyloid plaque. But while the readout partly addresses concerns about the molecule’s activity, ...

Acumen refers to the ability to think quickly, use good judgment and understand concepts, often in a particular area. Financial acumen refers to your ability to see the financial effects and ...

Acumen and JCR aim to develop a product leveraging Acumen’s amyloid beta oligomer-selective antibody expertise and JCR’s transferrin-receptor-targeting blood-brain barrier-penetrating technology ...

Acumen Pharmaceuticals has set the terms for its IPO, teeing it up to raise around $125 million to take an antibody against amyloid-beta oligomers to the end of phase 2 in Alzheimer’s disease.

Forbes contributors publish independent expert analyses and insights. Anne Field covers impact entrepreneurship and impact investing. A few years ago, Acumen, the pioneering patient capital impact ...

NEWTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that ...

CEO Dan O'Connell reported that Acumen completed enrollment of its 542-participant Phase 2 ALTITUDE-AD study evaluating Sabirnetug for early Alzheimer’s disease, stating, "We completed enrollment of ...

In a company, a manager seen as having general business acumen is one who consistently exercises sound judgment – the results of his decisions are most often favorable. Those he works with would say ...

If leadership is devoid of strategic acumen then the country can never be stable, prosperous and strong. Strategic acumen is a major requirement for a country like Pakistan which has passed through ...